| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: DNCR |
| Security Type |
Common Stock |
| Lead Underwriter |
UBS Warburg |
| Days In Registration |
49 |
| Date Filed |
29-Sep-2000 |
| Form Filed | F-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Healthcare |
| Business Description |
Provide diagnostic laboratory services on body fluids such as blood and urine and on tissues and other specimens including human cells, offering partnerships with academic medical centers, hospitals, and regional and community laboratories |
| Revenue |
$349.6M |
| Net Income |
$6.0M |
| Shares Outstanding (post-offering) |
16.88M |
| Contact |
Zbig S. Biskup |
| Number of Employees |
4100 |
|
| Original Filing Information |
| US |
| Shares Filed |
7.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
7.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
378.0K |
| File Amount |
$98.0M |
| File Price Range |
$15.00 - $13.00 |
| File Mid Price |
$14.00 |
Current Filing Information
(Amended 11-Oct-2000) |
|
US |
|
Shares Filed |
7.0M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
7.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$98.0M |
| · % Change from Original |
0.0 |
| File Price Range |
$15.00 - $13.00 |
| File Mid Price |
$14.00 |
|
